Neonatal Follow-Up 2: Foundations of Health: Cardio-Pulm-Endo and Opioids in NICU Follow-Up
Session: Neonatal Follow-Up 2: Foundations of Health: Cardio-Pulm-Endo and Opioids in NICU Follow-Up
Martina Palazzo
Doctor
Department of Odontostomatologic and Specialized Clinical Sciences, Polytechnic University of Marche, Ancona, Italy
Ancona, Marche, Italy
Data are presented as mean ± SD, median |25P 75P|, or %. Independent t-test, Chi-square test, Fisher test and Mann-Whitney test were used for the statistical analysis (*p < 0.05). GA: gestational age; BW: birth weight; TL: total length; HC: head circumference; SGA: small for gestational age; WT: weight; EN: enteral nutrition; PN: parenteral nutrition; CPAP: continuous positive airway pressure; RDS: respiratory distress syndrome; HMD: hyaline membrane disease; BPD: bronchopulmonary dysplasia; EOS: early onset sepsis; PDA: patent ductus arteriosus; PVL: periventricular leukomalacia; RBC: red blood cells; ROP: retinopathy of prematurity; LOS: late onset sepsis; NEC: necrotizing enterocolitis; IVH: intraventricular hemorrhage; SDS: standard deviation score; NPE: non protein energy.
Data are reported as mean ± SD. Paired t-test was used for the statistical analysis. COG: cognitive; MOT: motor; Glyc <40[Birth-6HOL]: at least one blood glucose concentration of less than 40 mg/dL within the first 6 hours of life; Glyc≥40[Birth-6HOL]: all blood glucose concentrations greater than 40 mg/dL within the first 6 hours of life.